Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients [1] (multiple letters)

New England Journal of Medicine

Volumn 351, Issue 2, 2004, Pages 188-189

  Owda, Ali K ^a   Alam, Muhammad G ^a   Kumar, Jayant ^a   Ureña Torres, Pablo A ^b   Chanard, Jacques ^c   Block, Geoffrey A ^d   Goodman, William G ^e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Clinique de l'Orangerie Aubervilliers   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d Denver Nephrologists   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; VITAMIN D DERIVATIVE; NAPHTHALENE DERIVATIVE;

BONE TURNOVER; CALCIUM BLOOD LEVEL; HEART ARRHYTHMIA; HEMODIALYSIS; HUMAN; LETTER; MORPHOMETRICS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; QT PROLONGATION; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; BLOOD; CHRONIC KIDNEY FAILURE; DRUG ADMINISTRATION; DRUG EFFECT; HEART RATE; NOTE; RENAL REPLACEMENT THERAPY; BONE REMODELING; PREDICTION AND FORECASTING; TREATMENT OUTCOME;

CALCIUM; DRUG ADMINISTRATION SCHEDULE; HEART RATE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; NAPHTHALENES; PARATHYROID HORMONE; RENAL DIALYSIS; BONE REMODELING; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 3042842888     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200407083510217     Document Type: Letter

References (0)